141. Modelling seasonal dynamics of secondary growth in RJernej Jevšenak, Jožica Gričar, Sergio Rossi, Peter Prislan, 2022, izvirni znanstveni članek Povzetek: The monitoring of seasonal radial growth of woody plants addresses the ultimate question of when, how and why trees grow. Assessing the growth dynamics is important to quantify the effect of environmental drivers and understand how woody species will deal with the ongoing climatic changes. One of the crucial steps in the analyses of seasonal radial growth is to model the dynamics of xylem and phloem formation based on increment measurements on samples taken at relatively short intervals during the growing season. The most common approach is the use of the Gompertz equation, while other approaches, such as general additive models (GAMs) and generalised linear models (GLMs), have also been tested in recent years. For the first time, we explored artificial neural networks with Bayesian regularisation algorithm (BRNNs) and show that this method is easy to use, resistant to overfitting, tends to yield s-shaped curves and is therefore suitable for deriving temporal dynamics of secondary tree growth. We propose two data processing algorithms that allow more flexible fits. The main result of our work is the XPSgrowth() function implemented in the radial Tree Growth (rTG) R package, that can be used to evaluate and compare three modelling approaches: BRNN, GAM and the Gompertz function. The newly developed function, tested on intra-seasonal xylem and phloem formation data, has potential applications in many ecological and environmental disciplines where growth is expressed as a function of time. Different approaches were evaluated in terms of prediction error, while fitted curves were visually compared to derive their main characteristics. Our results suggest that there is no single best fitting method, therefore we recommend testing different fitting methods and selection of the optimal one.
Ključne besede: artificial neural networks, cambium, generalized additive model, Gompertz function, growing season, intra-annual time series
Objavljeno v DiRROS: 21.07.2022; Ogledov: 493; Prenosov: 331
 Celotno besedilo (1,26 MB)
Gradivo ima več datotek! Več... |
142. Priporočila za zobozdravstveno obravnavo odraslih bolnikov z rakom glave in vratu v Sloveniji, zdravljenih z obsevanjemAleš Fidler, Aleksandar Aničin, Vojislav Didanovič, Tadej Dovšak, Boris Gašpirc, Aleš Grošelj, Andrej Kansky, Matic Koren, Jana Krapež, Hojka Kuralt, Marko Kuralt, Boštjan Lanišnik, Romana Mance Kristan, Jošt Pavčič, Luka Prodnik, Peter Pukl, Tadej Ostrc, Milan Kuhar, Eva Skalerič, Robert Šifrer, Valerija Skopec, Primož Strojan, 2022, izvirni znanstveni članek Povzetek: Priporočila za zobozdravstveno obravnavo bolnikov z rakom glave in vratu (RGV) v Sloveniji, zdravljenih z obsevanjem sledijo priporočilom The Royal College of Surgeons of England v sodelovanju z The British Society for Disability and Oral Health, dopolnjujejo Priporočila za obravnavo bolnikov z rakom glave in vratu v Sloveniji in hkrati upoštevajo obstoječe zmožnosti slovenskega zdravstvenega sistema. Namen priporočil je prepre-čevanje oz. zmanjšanje zapletov v ustni votlini, ki nastanejo zaradi obsevanja. Opredeljujejo način zobozdravstvene oskrbe pred, med in po zdravljenju raka na vseh treh nivojih zobozdra-vstvene oskrbe, kar zagotavlja njeno pravočasnost in dostopnost. Priporočila predstavljajo poenoteno mnenje vseh deležnikov na področju zobozdravstvene obravnave bolnikov z RGV v državi.
Ključne besede: onkologija, zobozdravstvena obravnava, obsevanje, ustna votlina, priporočila
Objavljeno v DiRROS: 14.07.2022; Ogledov: 592; Prenosov: 211
Celotno besedilo (1,45 MB) |
143. |
144. Patch testing with the European baseline series and 10 added allergens : single centre study of 748 patientsMojca Bizjak, Katja Adamič, Nisera Bajrović, Renato Eržen, Maja Jošt, Peter Kopač, Mitja Košnik, Nika Lalek, Mihaela Zidarn, Dejan Dinevski, 2022, izvirni znanstveni članek Povzetek: Background. The European baseline series (EBS) of contact allergens is subject to change. An allergen is considered for inclusion when routine patch testing of patients with suspected contact dermatitis results in ≥ 0.5% prevalence rate. Objectives. We aimed to determine the frequency of sensitizations to 30 EBS allergens and 10 locally added allergens. Additionally, we assessed the strength and evolution of reactions to all tested allergens and co-reactivity of additional allergens. Methods. Patch testing with our baseline series of 40 allergens was done in 748 consecutive adults. Tests were applied to the upper back and removed by patients after 48 hours. Readings were done on day 3 (D3) and D6 or D7 (D6/7). Positive reactions fulfilled the criteria of at least one plus (+) reaction. Retrospective analysis was done. Results. Eight allergens not listed in the EBS had ≥ 0.5% prevalence rate (i.e., cocamidopropyl betaine, thiomersal, disperse blue mix 106/124, 2-bromo-2-nitropropane-1,3-diol, diazolidinyl urea, propylene glycol, Compositae mix II, and dexamethasone-21-phosphate), and 16.6% of positive reactions would have been missed without D6/7 readings. Conclusion. We propose further studies to evaluate whether cocamidopropyl betaine, disperse blue mix 106/124, 2-bromo-2-nitropropane-1,3-diol, diazolidinyl urea, and Compositae mix II need to be added to the EBS.
Ključne besede: allergy and immunology -- diagnosis, hypersensitivity -- diagnosis, skin tests, clinical epidemiology, baseline series, contact sensitization, patch tests, simultaneous reactivity
Objavljeno v DiRROS: 24.06.2022; Ogledov: 566; Prenosov: 209
 Povezava na datoteko |
145. Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccinationUrška Janžič, Urška Bidovec, Katja Mohorčič, Loredana Mrak, Nina Fokter Dovnik, Marija Ivanović, Maja Ravnik, Marina Čakš, Erik Škof, Jerneja Debeljak, Peter Korošec, Matija Rijavec, 2022, izvirni znanstveni članek Povzetek: Background: SARS-CoV-2 vaccination in cancer patients is crucial to prevent severe COVID-19 disease course. Methods: This study assessed immunogenicity of cancer patients on active treatment receiving mRNA-based SARS-CoV-2 vaccine by detection of anti-SARS-CoV-2 S1 IgG antibodies in serum, before, after the first and second doses and 3 months after a complete primary course of vaccination. Results were compared with healthy controls. Results: Of 112 patients, the seroconversion rate was 96%. A significant reduction in antibody levels was observed 3 months after vaccination in patients receiving immune checkpoint inhibitors versus control participants (p < 0.001). Adverse events were mostly mild. Conclusion: Immunogenicity after mRNA-based vaccine in cancer patients is adequate but influenced by the type of anticancer therapy. Antibody levels decline after 3 months, and thus a third vaccination is warranted.
Ključne besede: onkološko zdravljenje, imunogenost, osnovno cepljenje mRNA, čvrsti tumorji, anticancer treatment, immunogenicity, mRNA-based vaccination, solid cancer
Objavljeno v DiRROS: 24.06.2022; Ogledov: 822; Prenosov: 337
Celotno besedilo (2,03 MB) |
146. Effect of hydroxychloroquine in hospitalized patients with Covid-19Peter Horby, Marion Mafham, Martin J. Landray, 2020, izvirni znanstveni članek Povzetek: Background: Hydroxychloroquine and chloroquine have been proposed as treatments for coronavirus disease 2019 (Covid-19) on the basis of in vitro activity and data from uncontrolled studies and small, randomized trials. Methods: In this randomized, controlled, open-label platform trial comparing a range of possible treatments with usual care in patients hospitalized with Covid-19, we randomly assigned 1561 patients to receive hydroxychloroquine and 3155 to receive usual care. The primary outcome was 28-day mortality. Results: The enrollment of patients in the hydroxychloroquine group was closed on June 5, 2020, after an interim analysis determined that there was a lack of efficacy. Death within 28 days occurred in 421 patients (27.0%) in the hydroxychloroquine group and in 790 (25.0%) in the usual-care group (rate ratio, 1.09; 95% confidence interval [CI], 0.97 to 1.23; P = 0.15). Consistent results were seen in all prespecified subgroups of patients. The results suggest that patients in the hydroxychloroquine group were less likely to be discharged from the hospital alive within 28 days than those in the usual-care group (59.6% vs. 62.9%; rate ratio, 0.90; 95% CI, 0.83 to 0.98). Among the patients who were not undergoing mechanical ventilation at baseline, those in the hydroxychloroquine group had a higher frequency of invasive mechanical ventilation or death (30.7% vs. 26.9%; risk ratio, 1.14; 95% CI, 1.03 to 1.27). There was a small numerical excess of cardiac deaths (0.4 percentage points) but no difference in the incidence of new major cardiac arrhythmia among the patients who received hydroxychloroquine. Conclusions: Among patients hospitalized with Covid-19, those who received hydroxychloroquine did not have a lower incidence of death at 28 days than those who received usual care. (Funded by UK Research and Innovation and National Institute for Health Research and others; RECOVERY ISRCTN number, ISRCTN50189673; ClinicalTrials.gov number, NCT04381936.).
Ključne besede: Covid-19 -- drug therapy, hydroxychloroquine, chloroquine
Objavljeno v DiRROS: 30.05.2022; Ogledov: 511; Prenosov: 291
Povezava na datoteko
Gradivo ima več datotek! Več... |
147. Dexamethasone in hospitalized patients with Covid-19Peter Horby, Wei Shen Lim, Martin J. Landray, 2021, izvirni znanstveni članek Povzetek: Background: Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progression to respiratory failure and death. Methods: In this controlled, open-label trial comparing a range of possible treatments in patients who were hospitalized with Covid-19, we randomly assigned patients to receive oral or intravenous dexamethasone (at a dose of 6 mg once daily) for up to 10 days or to receive usual care alone. The primary outcome was 28-day mortality. Here, we report the final results of this assessment. Results: A total of 2104 patients were assigned to receive dexamethasone and 4321 to receive usual care. Overall, 482 patients (22.9%) in the dexamethasone group and 1110 patients (25.7%) in the usual care group died within 28 days after randomization (age-adjusted rate ratio, 0.83; 95% confidence interval [CI], 0.75 to 0.93; P<0.001). The proportional and absolute between-group differences in mortality varied considerably according to the level of respiratory support that the patients were receiving at the time of randomization. In the dexamethasone group, the incidence of death was lower than that in the usual care group among patients receiving invasive mechanical ventilation (29.3% vs. 41.4%; rate ratio, 0.64; 95% CI, 0.51 to 0.81) and among those receiving oxygen without invasive mechanical ventilation (23.3% vs. 26.2%; rate ratio, 0.82; 95% CI, 0.72 to 0.94) but not among those who were receiving no respiratory support at randomization (17.8% vs. 14.0%; rate ratio, 1.19; 95% CI, 0.92 to 1.55). Conclusions: In patients hospitalized with Covid-19, the use of dexamethasone resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxygen alone at randomization but not among those receiving no respiratory support. (Funded by the Medical Research Council and National Institute for Health Research and others; RECOVERY ClinicalTrials.gov number, NCT04381936; ISRCTN number, 50189673.).
Ključne besede: Covid-19 -- drug therapy, dexamethasone
Objavljeno v DiRROS: 30.05.2022; Ogledov: 512; Prenosov: 334
Povezava na datoteko
Gradivo ima več datotek! Več... |
148. The influence of the hot-rolling technique for EN AW-8021B aluminium alloy on the microstructural properties of a cold-rolled foilJakob Kraner, Tomaž Smolar, Darja Volšak, Marjana Lažeta, Robert Skrbinek, Damijan Fridrih, Peter Cvahte, Matjaž Godec, Irena Paulin, 2021, izvirni znanstveni članek Ključne besede: aluminium alloys, hot rolling, microstructure, EBSD, burst test
Objavljeno v DiRROS: 06.05.2022; Ogledov: 515; Prenosov: 138
Povezava na datoteko |
149. Impact and fracture toughness of nano-bainitic steel with low retained austeniteMihael Brunčko, Peter Kirbiš, Tomaž Irgolič, Darja Feizpour, Tomaž Vuherer, 2021, objavljeni povzetek znanstvenega prispevka na konferenci Ključne besede: nanostructured bainite, retained austenite, low temperature baite formation, impact toughness, fracture toughness
Objavljeno v DiRROS: 06.05.2022; Ogledov: 494; Prenosov: 132
Povezava na datoteko |
150. Population differentiation in Acer platanoides L. at the regional scale—laying the basis for effective conservation of its genetic resources in AustriaDesanka Lazarević, Jan-Peter George, Mari Rusanen, Dalibor Ballian, Stefanie Pfattner, Konrad Heino, 2022, izvirni znanstveni članek Povzetek: Norway maple (Acer platanoides L.) is a widespread forest tree species in Central and Northern Europe but with a scattered distribution. In the debate on climate change driven changes in species selection in the forest, Norway maple has recently received raised interest because of its comparatively high drought resistance (higher than in sycamore maple). Therefore, it is an interesting species for sites high in carbonates and where other native tree species have become devastated by pathogens (e.g., elm, ash). In Austria, the demand on saplings is currently rising, while there is only very little domestic reproductive material available (on average more than 95% of saplings are imported from neighboring countries). This study was undertaken to identify genetic diversity and population structure of Norway maple in Austria to lay the foundation for the establishment of respective in situ and ex situ conservation measures. In addition, samples from planted stands and imported reproductive material from other countries were included to study the anthropogenic influence on the species in managed forests. We used 11 novel microsatellites to genotype 756 samples from 27 putatively natural Austrian populations, and 186 samples derived from two planted stands and five lots of forest reproductive material; in addition, 106 samples from other European populations were also genotyped. Cross species amplification of the new markers was tested in 19 Acer species from around the world. Population clustering by STRUCTURE analysis revealed a distinct pattern of population structure in Austria and Europe, but overall moderate differentiation. Sibship analysis identifies several populations with severe founding effects, highlighting the need for proper selection of seed sources of sufficient genetic diversity in the species.
Ključne besede: Norway maple, genetic structure, genetic differentiation, gene pool, seed orchard
Objavljeno v DiRROS: 26.04.2022; Ogledov: 661; Prenosov: 424
Celotno besedilo (3,20 MB)
Gradivo ima več datotek! Več... |
